Crossmark

A tumor microenvironment integrated (TMI) staging system for pancreatic ductal adenocarcinoma based on cancer-associated fibroblast and molecular consensus signatures

Crossref DOI link: https://doi.org/10.1007/s12672-026-05091-0

Published Online: 2026-04-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yeo, Samuel Jianjie

Sim, Ian Tate Ek Ern

Tay, Hui Yi

Tai, David

Shi, Ruoyu

Chan, Jason Yongsheng
Funding

Funding for this research was provided by:

Singapore Ministry of Health’s National Medical Research Council (Research Transition Award (TA21jun-0005), Clinician Scientist Individual Research Grant (CIRG25jan-0007), Large Collaborative Grant (OFLCG-23May0039), and TETRAD II Collaborative Centre Grant (CG21APR2002))

SingHealth Duke-NUS AM/ACP-Designated Philanthropic Fund Grant Award (08/FY2023/EX/27-A65)

Duke-NUS Medical School and the “Estate of Tan Sri Khoo Teck Puat” (Khoo Bridge Funding Award (Duke-NUS-KBrFA/2025/0090))

Tanoto Foundation

NCCS Cancer fund
License Information

Text and Data Mining valid from 2026-04-25

Accepted Manuscript valid from 2026-04-25
More Information

Article History

Received: 6 January 2026

Accepted: 22 April 2026

First Online: 25 April 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below